Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Liponeurocytoma: Systematic review of a rare entity.

Gembruch O, Junker A, Mönninghoff C, Ahmadipour Y, Oppong MD, Sure U, El Hindy N, Lemonas E.

World Neurosurg. 2018 Sep 8. pii: S1878-8750(18)32021-7. doi: 10.1016/j.wneu.2018.09.001. [Epub ahead of print] Review.

PMID:
30205225
2.

Cerebellar liponeurocytoma - a rare entity: a case report.

Gembruch O, Junker A, Ahmadipour Y, Sure U, Lemonas E.

J Med Case Rep. 2018 Jun 17;12(1):170. doi: 10.1186/s13256-018-1706-z.

3.

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.

Schultz V, van der Meer F, Wrzos C, Scheidt U, Bahn E, Stadelmann C, Brück W, Junker A.

Glia. 2017 Aug;65(8):1350-1360. doi: 10.1002/glia.23167. Epub 2017 May 31.

4.

Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to Inflammation.

Voigt D, Scheidt U, Derfuss T, Brück W, Junker A.

Int J Mol Sci. 2017 Apr 4;18(4). pii: E760. doi: 10.3390/ijms18040760.

5.

Teaching NeuroImages: Sonographic detection of intraneural perineurioma in therapy-refractory carpal tunnel syndrome.

Krogias C, Gold R, Schelle T, Böhm J, Junker A, Sure U, Uerschels AK.

Neurology. 2017 Mar 7;88(10):e85-e86. doi: 10.1212/WNL.0000000000003692. No abstract available.

PMID:
28265045
6.

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.

Gerdes LA, Held K, Beltrán E, Berking C, Prinz JC, Junker A, Tietze JK, Ertl-Wagner B, Straube A, Kümpfel T, Dornmair K, Hohlfeld R.

Ann Neurol. 2016 Aug;80(2):294-300. doi: 10.1002/ana.24715. Epub 2016 Jul 15.

7.

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?

Abdelhak A, Junker A, Brettschneider J, Kassubek J, Ludolph AC, Otto M, Tumani H.

Int J Mol Sci. 2015 Jul 31;16(8):17565-88. doi: 10.3390/ijms160817565. Review.

8.

Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.

Mohan H, Friese A, Albrecht S, Krumbholz M, Elliott CL, Arthur A, Menon R, Farina C, Junker A, Stadelmann C, Barnett SC, Huitinga I, Wekerle H, Hohlfeld R, Lassmann H, Kuhlmann T, Linington C, Meinl E.

Acta Neuropathol Commun. 2014 Dec 11;2:168. doi: 10.1186/s40478-014-0168-9.

9.

Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.

Junker A, Brück W.

Curr Opin Neurol. 2012 Jun;25(3):349-57. doi: 10.1097/WCO.0b013e3283534a8a. Review.

PMID:
22543404
10.

MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions.

Lescher J, Paap F, Schultz V, Redenbach L, Scheidt U, Rosewich H, Nessler S, Fuchs E, Gärtner J, Brück W, Junker A.

J Neuroimmunol. 2012 May 15;246(1-2):27-33. doi: 10.1016/j.jneuroim.2012.02.012. Epub 2012 Mar 22.

PMID:
22445295
11.

Prospects of transcript profiling for mRNAs and MicroRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions.

Eisele S, Krumbholz M, Fischer MT, Mohan H, Junker A, Arzberger T, Hohlfeld R, Bradl M, Lassmann H, Meinl E.

Brain Pathol. 2012 Sep;22(5):607-18. doi: 10.1111/j.1750-3639.2012.00564.x. Epub 2012 Feb 13.

PMID:
22233114
12.

Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.

Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM; NeuroproMiSe EBV Working Group.

Brain. 2011 Sep;134(Pt 9):2772-86. doi: 10.1093/brain/awr197. Epub 2011 Aug 16.

13.

Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and their relation to local T-cell infiltrates.

Held K, Junker A, Dornmair K, Meinl E, Sinicina I, Brandt T, Theil D, Derfuss T.

J Virol. 2011 Oct;85(19):9680-5. doi: 10.1128/JVI.00874-11. Epub 2011 Jul 27.

14.

Pathophysiology of translational regulation by microRNAs in multiple sclerosis.

Junker A.

FEBS Lett. 2011 Dec 1;585(23):3738-46. doi: 10.1016/j.febslet.2011.03.052. Epub 2011 Mar 29. Review.

15.

The emerging role of microRNAs in multiple sclerosis.

Junker A, Hohlfeld R, Meinl E.

Nat Rev Neurol. 2011 Jan;7(1):56-9. doi: 10.1038/nrneurol.2010.179. Epub 2010 Dec 14. Review.

PMID:
21151203
16.

Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells.

Mohan H, Krumbholz M, Sharma R, Eisele S, Junker A, Sixt M, Newcombe J, Wekerle H, Hohlfeld R, Lassmann H, Meinl E.

Brain Pathol. 2010 Sep;20(5):966-75. doi: 10.1111/j.1750-3639.2010.00399.x. Epub 2010 Mar 25.

PMID:
20456365
17.

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E.

Brain. 2009 Dec;132(Pt 12):3342-52. doi: 10.1093/brain/awp300.

PMID:
19952055
18.

Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.

Meinl E, Krumbholz M, Derfuss T, Junker A, Hohlfeld R.

J Neurol Sci. 2008 Nov 15;274(1-2):42-4. doi: 10.1016/j.jns.2008.06.032. Epub 2008 Aug 19. Review.

PMID:
18715571
19.

Multiple sclerosis: T-cell receptor expression in distinct brain regions.

Junker A, Ivanidze J, Malotka J, Eiglmeier I, Lassmann H, Wekerle H, Meinl E, Hohlfeld R, Dornmair K.

Brain. 2007 Nov;130(Pt 11):2789-99. Epub 2007 Sep 21.

PMID:
17890278

Supplemental Content

Loading ...
Support Center